Li Y N, Tattam B, Brown K F, Seale J P
Department of Pharmacy, University of Sydney, NSW, Australia.
J Chromatogr B Biomed Appl. 1996 Aug 30;683(2):259-68. doi: 10.1016/0378-4347(96)00111-9.
A highly sensitive and selective method has been developed for the simultaneous quantification of 22R- and 22S-epimers of budesonide in human plasma. The drug was isolated from human plasma using C18 solid-phase extraction cartridges and was acetylated with a mixture of 12.5% acetic anhydride and 12.5% triethylamine in acetonitrile to form the 21-acetyl derivatives. Deuterium-labelled budesonide was synthesized and determined to have an isotopic purity > 99%. This was used as the internal standard. Epimers were quantified by automated liquid chromatography-atmospheric pressure chemical ionization mass spectrometry, operating in selected ion mode at m/z 473.2 and m/z 476.2. Linear responses were observed for both epimers over the range 0.25 to 10.0 ng/ml. The average recoveries of 22R- and 22S-epimers of budesonide from human plasma were 87.4% and 87.0%, respectively. The lower limit of quantification for each epimer was 0.25 ng/ml, corresponding to 50.0 pg of analyte on column. Within- and between-day coefficients of variation were 8.6% and 4.0%, respectively.
已开发出一种高灵敏度和高选择性的方法,用于同时定量测定人血浆中布地奈德的22R-和22S-差向异构体。使用C18固相萃取柱从人血浆中分离出该药物,并用12.5%乙酸酐和12.5%三乙胺的乙腈混合物将其乙酰化,以形成21-乙酰基衍生物。合成了氘代布地奈德,其同位素纯度>99%。将其用作内标。通过自动液相色谱-大气压化学电离质谱法对差向异构体进行定量,在选定离子模式下于m/z 473.2和m/z 476.2处进行操作。两种差向异构体在0.25至10.0 ng/ml范围内均观察到线性响应。布地奈德的22R-和22S-差向异构体从人血浆中的平均回收率分别为87.4%和87.0%。每种差向异构体的定量下限为0.25 ng/ml,相当于柱上50.0 pg的分析物。日内和日间变异系数分别为8.6%和4.0%。